临床研究员:竞争前研究通过建模和模拟推动药物开发的现代化

It’s hard to imagine that 37 leading, global biopharmaceutical companies would be willing to partner to develop a new technology and progress a scientific field, but that is exactly what the members of the Simcyp Consortium have achieved. Working together in a pre-competitive, collaborative research environment, the consortium’s members are advancing physiologically based pharmacokinetic (PBPK) mechanistic modeling and simulation to predict pharmacokinetic/pharmacodynamic (PK/PD) outcomes in virtual patient populations…

Author(s): Rob Aspbury, PhD

返回顶部
Powered by Translations.com GlobalLink OneLink Software